Partnered with
Hi HAIFer,
This week marks 3500+ subscribers across HAIF’s newsletters: Health AI Market Intelligence (this one) and Health AI Deep Dives. We’re greatful to have you be part of this journey and making healthcare AI something we can all keep up with. Today’s issue is kindly supported by Doximity today.
Sponsored by: Doximity
DoxGPT is a HIPAA-compliant AI assistant designed for U.S. healthcare professionals. It streamlines clinical and administrative tasks by answering clinical questions with cited, evidence-based references - including integrated drug information -generating chart notes and documentation, and creating patient education materials.
DoxGPT integrates seamlessly with Doximity tools and ensures robust data security. Free for verified clinicians, DoxGPT reduces documentation burden and improves access to up-to-date medical knowledge, so you can focus more on patient care.
Your shortcut for this week:
Read on for the foresight of the week and the full breakdown of what shaped healthcare AI 👇
Solutions and Launches
Aible (US): Announced a Healthcare-focused AI agent solution (part of six new industry templates) that explains shifts in patient demand and facility performance; agents can run locally on NVIDIA DGX Spark to support secure, air-gapped analysis. [Link]
LEM Surgical (Switzerland/US): Announced plans to integrate NVIDIA’s Jetson Thor and Cosmos models into its FDA-cleared "Dynamis" robot to create fully autonomous "surgical humanoids." [Link]
South Korea Government (South Korea): Initiated a national bio-big data platform integrating 770,000 records to provide a secure foundation for validating and testing medical AI tools at scale. [Link]
Abbott (USA): Introduced "Libre Assist," a generative AI feature within its app that uses meal photos to predict glucose impact and provide personalized guidance for people with diabetes. [Link]
Governance, Policy, and Ethics
MIT (US): Researchers demonstrated that clinical AI models can "memorize" and leak anonymized patient data, proposing a new risk-assessment framework to prevent privacy breaches. [Link]
NHS England (UK): Announced the first nine priority conditions (including menopause and glaucoma) for the new "Online Hospital" service, aiming to shift 8.5 million appointments to the NHS App to reduce waiting lists. [Link]
Research and AI Advancements
MIT & VU Amsterdam: Published preprint "Explainable AI as a Double-Edged Sword in Dermatology". The study found that complex AI explanations paradoxically induced "automation bias" in lay users, leading them to trust and follow incorrect AI suggestions. [Link]
Research Institute of Economy, Trade, and Industry (Japan): A trial of 1,187 patients found that AI-driven empathic feedback significantly improved adherence to self-guided depression therapy. [Link]
Quality of Conventional versus Artificial Intelligence Oral Surgery Consent Forms: This study found that AI-generated consent forms demonstrated higher quality and better readability than standard web-based versions. [Link]
The Guardian’s investigation on Google AI: the investigation revealed "AI Overviews" providing inaccurate medical advice, such as contradicting dietary needs for cancer patients. Google stated that most summaries are accurate and it continues to improve quality and context. [Link]
Partnerships & Adoption
Healthee x Health Benefit Alliance (US): Integrating the "Zoe" AI assistant to automate benefits navigation for members. [Link]
Insilico Medicine x Servier (France): : Signed a deal worth up to $888M to use the Pharma.AI platform for oncology drug design. [Link]
Earendil Labs x Sanofi (Global): Entered a strategic collaboration worth up to $2.56B to discover bispecific antibodies for autoimmune diseases. [Link]
Bets on the Next Health System
Investments:
Leona Health (US/Mexico): Raised $14M in seed funding led by a16z to scale its WhatsApp-based AI clinician copilot across Latin America. [Link]
IGC Pharma (US): Raised ~$234k via a direct offering to fund Phase 2 trials for its AI-refined Alzheimer’s therapy. [Link]
Pragmatech (Ireland): Secured €650k to expand its AI clinical decision support tool for antibiotic prescribing. [Link]
Insilico Medicine (Hong Kong): Listed on the HKEX, raising HKD 2.27B (~$293M) to scale its end-to-end generative AI drug discovery pipeline.[Link]
M&A:
Voy (UK): Acquired weight-management provider Morelife to combine its digital health platform with Morelife's operational expertise to expand NHS capacity. [Link]
That’s a wrap for Edition #13 of Health AI Foresight.
My goal with this newsletter is simple - to connect the present, the emerging, and the future of healthcare AI.
See you next week.
- Dr. Aboufandi
📩 Something stand out? Or have a suggestion? Hit reply - I read every message.